Skip to main content
. 2021 Jul 8;9(7):761. doi: 10.3390/vaccines9070761

Figure 2.

Figure 2

SARS-CoV-2 structure and its affinity with human ACE2 receptor (adapted from Mahmood et al., 2021 [184]).